Partial irradiation of the liver

Seminars in Radiation Oncology

Volumn 11, Issue 3, 2001, Pages 240-246

  Dawson, Laura A ^b   Ten Haken, Randall K ^a   Lawrence, Theodore S ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABDOMINAL RADIOTHERAPY; BIOLOGICAL MODEL; CANCER RADIOTHERAPY; DOSE RESPONSE; FOLLOW UP; HUMAN; LIVER CANCER; LIVER INJURY; PRIORITY JOURNAL; RADIATION DOSE; RADIATION INJURY; REVIEW;

EID: 0034953364     PISSN: 10534296     EISSN: None     Source Type: Journal    
DOI: 10.1053/srao.2001.23485     Document Type: Article

References (34)

1. Hepatic toxicity resulting from cancer treatment
2. Escalated focal liver radiation and concurrent hepatic artery fluorodeoxyuridine for unresectable intrahepatic malignancies
3. Long-term results of hepatic artery fluorodeoxyuridine and conformal radation therapy for primary hepatobiliary cancers
4. Combined liver radiation and chemotherapy for palliation of hepatic metastases from colorectal cancer
5. Potential benefits of eliminating planning target volume expansions for patient breathing in the treatment of liver tumors
6. Treatment of intrahepatic cancers with radiation doses based on a normal tissue complication probability model
7. Use of Veff and iso-NTCP in the implementation of dose escalation protocols
8. Dose volume histogram analysis of liver radiation tolerance
9. The usefulness of radiation therapy for hepatocellular carcinoma
10. Complication probability as assessed from dose-volume histograms
11. Radiation hepatitis
12. Hepatic radiation tolerance in Hodgkin's disease patients
13. Accelerated hyperfractionated hepatic irradiation in the management of patients with liver metastases: Results of the RTOG dose escalating protocol
14. Conformal high-dose radiation plus intraarterial floxuridine for hepatic cancer
15. A phase I trial of hepatic arterial bromodeoxyuridine and conformal radiation therapy for patients with primary hepatobiliary cancers of colorectal liver metastases
16. Tolerance of normal tissue to therapeutic irradiation
17. Local radiotherapy for unresectable hepatocellular carcinoma patients who failed with transcatheter arterial chemoembolization
18. Local radiotherapy with or without transcatheter arterial chemoembolization for patients with unresectable hepatocellular carcinoma
19. Clearance of parenchymal tumors following radiotherapy: Analysis of hepatocellular carcinomas treated by proton beams
20. New, effective treatment using proton irradiation for unresectable hepatocellular carcinoma
21. Stereotactic high dose fraction radiation therapy of extracranial tumors using an accelerator. Clinical experience of the first thirty-one patients
22. Intrafractional tumor position stability during computed tomography (CT)-guided frameless stereotactic radiation therapy for lung or liver cancers with a fusion of CT and linear accelerator (FOCAL) unit
23. The use of 3-D dose volume analysis to predict radiation hepatitis
24. Calculation of complication probability factors for non-uniform normal tissue irradiation: The effective volume method
25. Fitting of normal tissue tolerance data to an analytic function
26. Determination of model parameters for description of radiation induced liver disease
27. Probability of radiation-induced complications for normal tissues with parallel architecture subject to non-uniform irradiation
28. Modeling of normal tissue response to radiation: The critical volume model
29. Probability of radiation-induced complications in normal tissues with parallel architecture under conditions of uniform whole or partial organ irradiation
30. Analysis of clinical complication data for radiation hepatitis using a parallel architecture model
31. Radiation pneumonitis as a function of mean lung dose: An analysis of pooled data of 540 patients
32. Uncertainties in CT-based radiation therapy treatment planning associated with patient breathing
33. Quantization of setup uncertainties in 3-D dose calculations
34. The reproducibility of active breathing control (ABC) during liver radiotherapy